Transcriptomics analysis of in vitro NASH models unveils potential adverse effect of elafibranor

Accession: GSE166186
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: expression microarray)
Modality / assay: bulk-array
Platform: Expression profiling by array; Third-party reanalysis, GPL570
Organism: human
Samples: 18
Size (indexed): 97.5 MB (102219571 bytes)
Downloaded bytes: 97.5 MB (102219571 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE166186_RAW.tar89.5 MB6591f47169c7eb84…
GSE166186_complete_processed_data.xls.gz8.0 MBb012096b2cb4bfe9…
filelist.txt1.4 KB497ca8e17d28cae3…

Index note: 3 suppl file(s); GSE166186_RAW.tar

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T19:11:46Z.

About this dataset

This Expression profiling by array; Third-party reanalysis, GPL570 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 18 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.